[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

C Tschöpe, E Ammirati, B Bozkurt… - Nature Reviews …, 2021 - nature.com
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …

Description and proposed management of the acute COVID-19 cardiovascular syndrome

NS Hendren, MH Drazner, B Bozkurt, LT Cooper Jr - Circulation, 2020 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) is a rapidly expanding global pandemic caused by
severe acute respiratory syndrome coronavirus 2, resulting in significant morbidity and …

Reappraising the role of inflammation in heart failure

L Adamo, C Rocha-Resende, SD Prabhu… - Nature Reviews …, 2020 - nature.com
The observation that heart failure with reduced ejection fraction is associated with elevated
circulating levels of pro-inflammatory cytokines opened a new area of research that has …

Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association

RD Kociol, LT Cooper, JC Fang, JJ Moslehi, PS Pang… - Circulation, 2020 - Am Heart Assoc
Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe
diffuse cardiac inflammation often leading to death resulting from cardiogenic shock …

Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association

B Bozkurt, M Colvin, J Cook, LT Cooper, A Deswal… - Circulation, 2016 - Am Heart Assoc
The first classification on this topic categorized cardiomyopathies as heart muscle diseases
with dilated (DCM), hypertrophic, restrictive, arrhythmogenic right ventricular (ARVC), or …

Dilated cardiomyopathy

RG Weintraub, C Semsarian, P Macdonald - The Lancet, 2017 - thelancet.com
Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and
contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal …

Update on the use of immunoglobulin in human disease: a review of evidence

EE Perez, JS Orange, F Bonilla, J Chinen… - Journal of Allergy and …, 2017 - Elsevier
Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Acute myocardial infarction in young individuals

R Gulati, A Behfar, J Narula, A Kanwar, A Lerman… - Mayo Clinic …, 2020 - Elsevier
Globally, cardiovascular disease remains a major cause of adverse outcomes in young
individuals, unlike its decline in other age groups. This group is not well studied and has a …

Chronic heart failure and inflammation: what do we really know?

SA Dick, S Epelman - Circulation research, 2016 - Am Heart Assoc
As a greater proportion of patients survive their initial cardiac insult, medical systems
worldwide are being faced with an ever-growing need to understand the mechanisms …

Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry

E Ammirati, M Cipriani, C Moro, C Raineri, D Pini… - Circulation, 2018 - Am Heart Assoc
Background: There is controversy about the outcome of patients with acute myocarditis (AM),
and data are lacking on how patients admitted with suspected AM are managed. We report …